
Personalised cancer vaccine cuts risk of skin cancer returning
A personalised cancer vaccine given with a widely used immunotherapy cut the risk of patients dying or their skin cancer returning by 42% in a major trial. Researchers say it could mark a turning point for personalised medicine, the BBC reports.
Read more at BBC News →















